FGAM
Financial Gravity Asset Management Portfolio holdings
AUM
$459M
This Quarter Return
-2.34%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$9.07B
AUM Growth
+$9.04B
(+24,600%)
Cap. Flow
+$6.8B
Cap. Flow
% of AUM
74.98%
Top 10 Holdings %
Top 10 Hldgs %
35.93%
Holding
1,967
New
366
Increased
412
Reduced
318
Closed
808
Top Buys
| 1 |
SPDR Portfolio S&P 600 Small Cap ETF
SPSM
|
+$257M |
| 2 |
SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$190M |
| 3 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$182M |
| 4 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$173M |
| 5 |
Coca-Cola
KO
|
+$163M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$157M |
| 2 |
Broadcom
AVGO
|
+$15.9M |
| 3 |
Western Digital
WDC
|
+$12.1M |
| 4 |
Micron Technology
MU
|
+$11.6M |
| 5 |
Invesco S&P 500 Top 50 ETF
XLG
|
+$5.09M |
Sector Composition
| 1 | Technology | 7.69% |
| 2 | Consumer Discretionary | 6.1% |
| 3 | Consumer Staples | 6.01% |
| 4 | Communication Services | 5.71% |
| 5 | Healthcare | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
nVent Electric
NVT
$15.5B
| $442 | ﹤0.01% |
9
-43
| -83% | -$2.11K |
|
577
Pearson
PSO
$9.21B
| $441 | ﹤0.01% |
38
+28
| +280% | +$325 |
|
578
West Pharmaceutical
WST
$18.8B
| $436 | ﹤0.01% |
1
-381
| -100% | -$166K |
|
579
CorVel
CRVL
$4.49B
| $435 | ﹤0.01% |
+6
| New | +$435 |
|
580
FTI Consulting
FCN
$5.33B
| $434 | ﹤0.01% |
+1
| New | +$434 |
|
581
FlexShares High Yield Value-Scored Bond Index Fund
HYGV
$1.24B
| $428 | ﹤0.01% |
10
-30
| -75% | -$1.28K |
|
582
ProShares UltraShort S&P500
SDS
$468M
| $413 | ﹤0.01% |
+11
| New | +$413 |
|
583
Curtiss-Wright
CW
$19.2B
| $406 | ﹤0.01% |
+2
| New | +$406 |
|
584
W.R. Berkley
WRB
$27.7B
| $406 | ﹤0.01% |
6
-84
| -93% | -$5.68K |
|
585
DaVita
DVA
$9.55B
| $403 | ﹤0.01% |
+4
| New | +$403 |
|
586
Elevance Health
ELV
$71.2B
| – | – |
-444
| Closed | -$1.91K |
|
587
Wipro
WIT
$29B
| $390 | ﹤0.01% |
170
+160
| +1,600% | +$367 |
|
588
Delta Air Lines
DAL
$39B
| $385 | ﹤0.01% |
13
-35
| -73% | -$1.04K |
|
589
Zimmer Biomet
ZBH
$20.6B
| $384 | ﹤0.01% |
2
-144
| -99% | -$27.6K |
|
590
PACCAR
PCAR
$53.3B
| $378 | ﹤0.01% |
4
-80
| -95% | -$7.56K |
|
591
FlexShares Ultra-Short Income Fund
RAVI
$1.37B
| $372 | ﹤0.01% |
+5
| New | +$372 |
|
592
Globe Life
GL
$11.5B
| $369 | ﹤0.01% |
+3
| New | +$369 |
|
593
Parker-Hannifin
PH
$98.6B
| – | – |
-390
| Closed | -$12.1K |
|
594
Raymond James Financial
RJF
$34B
| $368 | ﹤0.01% |
3
-101
| -97% | -$12.4K |
|
595
Arch Capital
ACGL
$34.1B
| $366 | ﹤0.01% |
4
-71
| -95% | -$6.5K |
|
596
Santander
BSBR
$40.9B
| $366 | ﹤0.01% |
71
+65
| +1,083% | +$335 |
|
597
Baker Hughes
BKR
$46.5B
| $355 | ﹤0.01% |
10
-22
| -69% | -$781 |
|
598
NRG Energy
NRG
$30.9B
| $350 | ﹤0.01% |
9
-28
| -76% | -$1.09K |
|
599
ProShares Ultra NASDAQ Biotechnology
BIB
$56.8M
| $348 | ﹤0.01% |
+8
| New | +$348 |
|
600
Assurant
AIZ
$10.6B
| $345 | ﹤0.01% |
+3
| New | +$345 |
|